Showing 1 - 6 results of 6 for search 'Mariusz L Hartman', query time: 0.03s Refine Results
  1. 1
    Non-Apoptotic Cell Death Signaling Pathways in Melanoma

    Non-Apoptotic Cell Death Signaling Pathways in Melanoma by Mariusz L. Hartman

    Published 2020-04-01
    Get full text
    Article
  2. 2
    Pro-Apoptotic Activity of MCL-1 Inhibitor in Trametinib-Resistant Melanoma Cells Depends on Their Phenotypes and Is Modulated by Reversible Alterations Induced by Trametinib Withdrawal

    Pro-Apoptotic Activity of MCL-1 Inhibitor in Trametinib-Resistant Melanoma Cells Depends on Their Phenotypes and Is Modulated by Reversible Alterations Induced by Trametinib Withdr... by Mariusz L. Hartman, Paulina Koziej, Katarzyna Kluszczyńska, Małgorzata Czyz

    Published 2023-09-01
    Get full text
    Article
  3. 3
    Trametinib-Resistant Melanoma Cells Displaying MITF<sup>high</sup>/NGFR<sup>low</sup>/IL-8<sup>low</sup> Phenotype Are Highly Responsive to Alternating Periods of Drug Withdrawal and Drug Rechallenge

    Trametinib-Resistant Melanoma Cells Displaying MITF<sup>high</sup>/NGFR<sup>low</sup>/IL-8<sup>low</sup> Phenotype Are Highly Responsive to Alternating Periods of Drug Withdrawal a... by Paulina Koziej, Katarzyna Kluszczynska, Mariusz L. Hartman, Malgorzata Czyz

    Published 2023-04-01
    Get full text
    Article
  4. 4
    Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity

    Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity by Mariusz L. Hartman, Malgorzata Sztiller-Sikorska, Anna Gajos-Michniewicz, Malgorzata Czyz

    Published 2020-01-01
    Get full text
    Article
  5. 5
    17-Aminogeldanamycin Inhibits Constitutive Nuclear Factor-Kappa B (NF-κB) Activity in Patient-Derived Melanoma Cell Lines

    17-Aminogeldanamycin Inhibits Constitutive Nuclear Factor-Kappa B (NF-κB) Activity in Patient-Derived Melanoma Cell Lines by Mariusz L. Hartman, Magdalena Rogut, Aleksandra Mielczarek-Lewandowska, Michal Wozniak, Malgorzata Czyz

    Published 2020-05-01
    Get full text
    Article
  6. 6
    Exogenous growth factors bFGF, EGF and HGF do not influence viability and phenotype of V600EBRAF melanoma cells and their response to vemurafenib and trametinib in vitro.

    Exogenous growth factors bFGF, EGF and HGF do not influence viability and phenotype of V600EBRAF melanoma cells and their response to vemurafenib and trametinib in vitro. by Izabela Zalesna, Marta Osrodek, Mariusz L Hartman, Michal Rozanski, Malgorzata Sztiller-Sikorska, Karolina Niewinna, Dariusz Nejc, Malgorzata Czyz

    Published 2017-01-01
    Get full text
    Article

Search Tools: